Literature DB >> 22710499

Refractory Salmonella enterica serotype choleraesuis-related renal cyst infection in a patient with autosomal dominant polycystic kidney disease undergoing hemodialysis treated successfully with intracystic ciprofloxacin infusion.

Chih-Chao Yang1, Feng-Rong Chuang, Chien-Hsing Wu, Jin-Bor Chen, Chih-Hsiung Lee, Chien-Te Lee.   

Abstract

OBJECTIVE: To report a potential salvage therapy for refractory renal cyst infection secondary to Salmonellaenterica serotype choleraesuis (S. choleraesuis). CLINICAL PRESENTATION AND INTERVENTION: A 52-year-old male with autosomal dominant polycystic kidney disease undergoing hemodialysis experienced an episode of S. choleraesuis-related gastroenteritis subsequently complicated by bloodstream and refractory renal cyst infection with formation of multiple pyocysts. The patient was treated with intracystic indwelling diluted ciprofloxacin solution.
CONCLUSION: In this patient, intracystic infusion of ciprofloxacin achieved a sufficient antibiotic level in infected renal cysts and hence completely eradicated S. choleraesuis. Therefore, intracystic antiobiotic infusion could be a potential salvage therapy for refractory renal cyst infection.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22710499     DOI: 10.1159/000339199

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  3 in total

Review 1.  Current management of autosomal dominant polycystic kidney disease.

Authors:  Jacob A Akoh
Journal:  World J Nephrol       Date:  2015-09-06

2.  Concurrent Salmonella mycotic abdominal aneurysm and empyema thoracis: a rare coincidence.

Authors:  Chia-Ter Chao
Journal:  Med Princ Pract       Date:  2014-01-31       Impact factor: 1.927

Review 3.  Infectious Disease Risk in Dialysis Patients: A Transdisciplinary Approach.

Authors:  Caroline Lamarche; Ioan-Andrei Iliuta; Thomas Kitzler
Journal:  Can J Kidney Health Dis       Date:  2019-04-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.